This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San Diego

Scientific Program Partner

Meeting agenda created in conjunction with The Antibody Society.

December 14 - 17, 2025|Marriott Marquis San Diego

Protein Engineering Excellence

Accelerating Tomorrow's Antibody Therapeutics Today

The Summit of Antibody Science and Your Path to Commercial Success

Antibodies • Proteins • Bispecifics • Multispecifics • ADCs • AI • Computational Breakthroughs

Bispecific Savings: Bind Your Hotel and Registration Savings Today

If you are traveling to San Diego, be sure to book our discounted hotel room block directly at the Marriott Marquis San Diego. Only a few rooms remain so book your discounted hotel room and secure your early bird attendee ticket today to maximize your savings.

Antibody Engineering is Experiencing Unprecedented Innovation. Are You Leading or Following?

Antibody Engineering & Therapeutics isn't just an event - it's a strategic investment for your R&D teams to fast-track antibodies from discovery to the clinic and beyond by applying cutting-edge innovation across AI, computational breakthroughs and beyond.

Novel Bispecific and Multi-specific Antibodies

  • Explore advanced multispecific formats to overcome therapeutic limitations

  • Case studies on bispecific ADCs and conditional activation platforms

  • Engineering strategies for glycan targeting, avidity, and stability

Antibody Therapeutics in Emerging Disease Areas: Non-Oncology

  • Novel antibodies for fibrosis, cardiovascular disease, and CNS delivery

  • Innovative biologics targeting innate and adaptive immune pathways

  • Translating discoveries into therapies for complex non-oncology indications

Innovative Engineering for Cell Engagers

  • AI-driven design and next-gen T-cell engager platforms

  • Strategies to improve potency, selectivity, and safety in immunotherapy

  • Novel conditional engagers and dual-binding antibodies in cancer therapy

Antibody and Protein Therapeutics in Inflammation, Autoimmunity and Allergy

  • Breakthroughs in cell depletion strategies for autoimmune diseases

  • Next-gen cytokine blockers and trispecific antibodies for inflammation

  • Novel approaches to allergy treatment, from IgE cleavage to immune modulation

Emerging In Vitro Approaches to Antibody Discovery

  • Cutting-edge display technologies and high-throughput screening platforms

  • Computational and AI-driven antibody engineering for speed and precision

  • Case studies on de novo antibody design and rapid evolution systems

Engineering Innovative Formats and Scaffolds

  • Nanobody and knottin engineering for novel therapeutic applications

  • Advances in GPCR-targeting formats and allosteric modulators

  • Overcoming immunogenicity challenges with new scaffold architectures

Advanced In Vivo Antibody Discovery

  • Leveraging animal models and immune organoids for breakthrough discovery

  • In vivo screening approaches for CNS delivery and biodistribution

  • Strategies to accelerate discovery of antibodies against infectious diseases

Antibody Drug Conjugates - Novel Payloads and Engineering

  • Dual-payload ADCs for enhanced efficacy and resistance management

  • Site-specific conjugation techniques for stability and safety

  • Novel non-cytotoxic payloads and improved therapeutic index strategies

Engineering Considerations for Candidate Selection and Developability

  • Early risk mitigation for immunogenicity and chemical liabilities

  • ML-driven workflows for predictive developability optimization

  • High-throughput strategies for complex biologics like ADCs and bispecifics

Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics

  • Investor perspectives on value creation and biotech funding trends

  • Lessons from successful preclinical-to-clinic transitions

  • Strategic insights for commercialization and portfolio optimization

Enhanced Efficacy Through Fc Engineering

  • Fc modifications to optimize effector function and immune activation

  • Site-specific conjugation and glycoengineering breakthroughs

  • Translating Fc innovations into next-gen therapeutics

Novel Extracellular Protein Degraders & Beyond

  • Cutting-edge eTPD platforms for transmembrane and extracellular targets

  • Novel bispecific degrader technologies and conjugate strategies

  • Expanding the druggable proteome beyond traditional antibody modalities

What’s Waiting for You in Sunny San Diego

+

World-Class Speaker Presentations

+

Antibody Scientists & Executives

+

Leading Industry Exhibitors

+

Scientific Posters Highlighting Breakthrough Research

The Antibody Event That Sets the Agenda For 2026

Some conferences try to be everything to everyone - a sprawling buffet of topics where you leave full, but not always satisfied.

Antibody Engineering & Therapeutics US is different. The global community comes together this December in San Diego for the one event that’s exclusively about antibody engineering and therapeutic development.

That means every speaker, poster, and exhibitor you encounter is handpicked to feed your antibody pipeline - no filler, just the insights, data, and connections that matter.

Ways to Attend

Join the Antibody Event of the Year in San Diego!

Get ready for 4 days of breakthrough science, powerful networking, and cutting-edge innovation at Antibody Engineering & Therapeutics US. This is your chance to:

✔ Access exclusive insights from 135+ world-renowned speakers sharing never-before-seen data and real-world case studies.
✔ Connect with 75+ leading solution providers driving the next wave of antibody engineering and therapeutic development.
✔ Explore the entire antibody landscape - from discovery and design to clinical development and commercialization.

Whether you’re passionate about bispecifics, ADCs, AI-driven discovery, or next-gen formats, this is where the future of antibody therapeutics takes shape.

Join us in sunny San Diego or tune in virtually from anywhere!

Showcase Your Research – Add a Poster Presentation

When you register for an in-person or digital Main Conference Pass (or Main Conference + Workshop Pass), you’ll have the exclusive opportunity to elevate your experience by adding a poster presentation for just $199.

This is your chance to:
✔ Showcase your research to leading scientists and industry innovators
✔ Spark meaningful discussions and gain valuable feedback
✔ Expand your professional visibility within the global antibody community

Don’t miss this opportunity to amplify your presence and make an impact!

Partner with the World’s Leading Antibody Event

Seize the opportunity to connect with key decision-makers and industry pioneers shaping the future of antibody therapeutics. As a sponsor of Antibody Engineering & Therapeutics US, your brand will be front and center at the industry’s most influential event, giving you:

✔ Unparalleled access to top biopharma leaders and innovators
✔ Opportunities to showcase your solutions to an engaged audience actively seeking new technologies and partnerships
✔ Direct connections that accelerate your business growth in the antibody and protein therapeutics market

Don’t miss your chance to position your brand at the forefront of antibody innovation.

Michael Kierny, PhD

Scientist I

AstraZeneca

With fascinating presentations from high caliber speakers, the Antibody Engineering conference is essential to understanding the advances in the field.

The Antibody Society: Driving the Future of Antibody Science

The Antibody Society is a global non-profit organization uniting researchers, developers, and industry leaders advancing antibody science. Through data analysis, publications, webinars, and symposia, we connect the community with the insights and standards that shape next-generation therapeutics. We’re also proud to serve as the home of the Adaptive Immune Receptor Repertoire (AIRR) Community, dedicated to innovation and best practice in sequencing antibodies and T cell receptors.

Our members play a vital role as Scientific Advisors for the Antibody Engineering & Therapeutics conferences, ensuring each program reflects the very latest breakthroughs in discovery, development, and delivery.

👉 Special Benefit for Members: Antibody Society members enjoy exclusive savings on conference registration — including 15% off Antibody Engineering & Therapeutics US 2025.

Engage Quality Decision-Makers at Antibody Engineering & Therapeutics US!

Whether you're looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

Contact us to begin customizing your event presence today:

Companies A-L: Mia Crisafulli, MCrisafulli@informaconnectls.com

Companies M-Z: Blake Shuka, BShuka@informaconnectls.com

Vaishali Kapoor

Instructor

Washington University in St. Louis School of Medicine

Great meeting! Good learning and networking experience.

FAQs

expand_less

What is Antibody Engineering & Therapeutics US?

Antibody Engineering & Therapeutics US is the premier conference for antibody science and innovation. For over 30 years, it has served as a global meeting place bringing together leading academic and industry experts to share cutting-edge research, technology advances, and therapeutic breakthroughs in antibody engineering.